Skip to main content Skip to navigation

Workshop / Seminar

School of Mechanical and Materials Engineering Seminar Series, “Engineering Advances in Neurology and Interventional Neuroradiology” Presented by Dr. Scott Rewinkel

Engineering Teaching Research Laboratory (ETRL), Pullman, WA
Meet the speak in ETRL 119 prior to the seminar, light refreshments will be served. The presentation will be in ETRL 101.
View location in Google Maps

About the event

Engineering Advances in Neurology and Interventional Neuroradiology

Presented by

Dr. Scott Rewinkel, Stroke Medical Director, St. Charles Health System, OHSU Department of Neurology



New and repurposed technologies, devices, and materials are radically changing treatment options and outcomes for patients suffering from certain neurological conditions including ischemic stroke, migraine headaches, refractory epilepsy, Parkinson’s disease, and essential tremor. Arguably, the greatest advances have occurred in the treatment of large vessel acute ischemic stroke.  In the last decade alone, treatment of these particularly debilitating strokes has fundamentally changed due to the emergence and evolution of mechanical clot retrieval devices; devices which allow surgeons to remove blood clots from arteries in the brain. Presented from the unique perspective of a WSU mechanical engineering graduate working in in the field of clinical neurology and interventional neuroradiology, join us for a discussion of the technologies currently leading to rapid advances in neurological care.


Dr. Scott Rewinkel is a board-certified vascular neurologist and current interventional neuroradiology fellow at Oregon Health and Science University (OHSU) in Portland, OR. He is the former Director of Neurology at the St. Charles Health System in Bend, OR.  Dr. Rewinkel has a Bachelor of Science degree in Mechanical Engineering from the University of Washington. He completed his Master of Science degree in Mechanical and Materials Engineering at Washington State University in 2009 with research interests in tricalcium phosphate bioceramics.